Vista Investment Partners II’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$486K Buy
8,443
+101
+1% +$5.8K 0.19% 102
2026
Q1
$506K Buy
8,342
+1
+0% +$58 0.23% 90
2025
Q4
$450K Sell
8,341
-1,184
-12% -$57K 0.19% 97
2025
Q3
$430K Buy
9,525
+297
+3% +$13.9K 0.2% 92
2025
Q2
$427K Sell
9,228
-614
-6% -$30.1K 0.21% 93
2025
Q1
$600K Sell
9,842
-3
-0% -$175 0.33% 68
2024
Q4
$557K Buy
+9,845
New +$550K 0.33% 70

Other funds holding BMY

Vista Investment Partners II's BMY Position: Q2 2026 in Review

Vista Investment Partners II increased its Bristol-Myers Squibb (BMY) stake by 1.2% in Q2 2026, buying an estimated $5.8K and bringing the position to 8,443 shares worth $486K. The position accounts for 0.19% of the portfolio, ranked #102.

Vista Investment Partners II first reported a position in BMY in Q4 2024 and has held it in 7 quarters since. The position peaked at $600K in Q1 2025. 1,400 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Vista Investment Partners II held 8,443 shares of Bristol-Myers Squibb worth $486K as of Q2 2026.
  • Vista Investment Partners II bought 101 Bristol-Myers Squibb shares in Q2 2026, an estimated $5.8K.
  • Bristol-Myers Squibb made up 0.19% of Vista Investment Partners II's portfolio in Q2 2026, its #102 holding.
  • Vista Investment Partners II first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 7 quarters since.
  • Vista Investment Partners II's Bristol-Myers Squibb position peaked at $600K in Q1 2025.
  • 1,400 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Vista Investment Partners II's 13F filing for Q2 2026, filed 21 Jul 2026.